Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ekso Bionics Holdings Inc EKSO

Healthcare Medical Devices
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a... see more

Recent & Breaking News (NDAQ:EKSO)

Ekso Bionics to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2019

GlobeNewswire September 23, 2019

Ekso Bionics® Unveils the Next Generation Exoskeleton for Neurorehabilitation

GlobeNewswire August 15, 2019

Ekso Bionics Reports Second Quarter 2019 Results

GlobeNewswire August 1, 2019

Ekso Bionics® to Report Second Quarter 2019 Financial Results on August 1, 2019

GlobeNewswire July 25, 2019

Ekso Bionics® Expands Its Medical Portfolio with Upper Body Exoskeleton for Rehabilitation

GlobeNewswire July 24, 2019

Ekso Bionics Announces Closing of $10 Million Public Offering

GlobeNewswire May 24, 2019

Ekso Bionics Announces Pricing of $10 Million Public Offering

GlobeNewswire May 22, 2019

Ekso Bionics Announces Proposed Public Offering of Common Stock and Warrants

GlobeNewswire May 21, 2019

Ekso Bionics®' EksoGT Exoskeleton Adopted in Singapore for Groundbreaking Clinical Study

GlobeNewswire May 6, 2019

Ekso Bionics Announces Appointment of Bill Shaw as Chief Commercial Officer

GlobeNewswire May 6, 2019

Kindred Hospital Rehabilitation Services Expands Pilot of Ekso Bionics®' EksoGT Exoskeleton to Enhance Stroke Rehabilitation Offering

GlobeNewswire May 3, 2019

Ekso Bionics Reports First Quarter 2019 Results

GlobeNewswire May 1, 2019

Ekso Bionics® to Report First Quarter 2019 Financial Results on May 1, 2019

GlobeNewswire April 24, 2019

Ekso Bionics Reports Fourth Quarter and Year End 2018 Results

GlobeNewswire February 28, 2019

Ekso Bionics® to Report Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019

GlobeNewswire February 21, 2019

Ekso Bionics Announces $100 Million Joint Venture to Develop the Exoskeleton Market in Asia

GlobeNewswire January 30, 2019

Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results

GlobeNewswire January 8, 2019

Ekso Bionics® Secures Purchase Orders for the EksoVest™ from Two Global Aerospace Manufacturers

GlobeNewswire December 10, 2018

Worldwide Adoption of Ekso Bionics® EksoGT™ Exoskeleton Allows Stroke and Spinal Cord Injury Patients to Take 100 Million Steps to Date

GlobeNewswire December 4, 2018

Ekso Bionics Reports Third Quarter 2018 Results

GlobeNewswire November 7, 2018